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We document the absence of carriage of Neisseria
meningitidis W-135 of the sequence type 11 in returning pil-
grims after the Hajj 2002. This finding contrasts with the
15% carriage rate we previously reported in pilgrims return-
ing from the Hajj 2001. The epidemiology of carriage may
be changing or may have been controlled by vaccination
and a policy of administering antibiotics to pilgrims from
countries with a high incidence of meningococcal disease. 
T
wo million pilgrims from all over the world congre-
gate for the annual Islamic pilgrimage to Mecca and
Medina in Saudi Arabia (Hajj pilgrimage). Because over-
crowding facilitates person-to-person transmission of
meningococci, this pilgrimage has been associated with
meningococcal disease outbreaks (1–3). An international
outbreak of serogroup W-135 meningococcal disease
occurred during the Hajj pilgrimages in 2000 and 2001
(4,5). The outbreak-associated W-135 strains were of a sin-
gle clone of the electrophoretic type (ET)-37 complex (6)
and were closely related to other meningococci with an
established propensity to cause disease clusters (7).
Several reports from all over the world have shown that
this W-135 outbreak strain affected not only pilgrims but
also household contacts of returning pilgrims and the com-
munity at large, with the potential of non–Hajj-related fur-
ther epidemics (8–12). As nasopharyngeal carriage is the
primary source of transmission (13), worldwide dissemi-
nation is thought to be due to pilgrims who acquired W-
135 carriage during the pilgrimage and introduced the
strain on return to their countries of origin (14). We previ-
ously reported a 15% carriage rate of Neisseria meningi-
tidis W-135 in Singaporean pilgrims returning from the
Hajj 2001, despite the fact that all were vaccinated with
quadrivalent polysaccharide meningococcal vaccine (15).
W-135 carriage was substantially transmitted to unvacci-
nated household contacts (15,16). Pulsed-field gel elec-
trophoresis (PFGE) of these isolates showed that they were
distinguishable in 83% of the samples (unpub. data), indi-
cating that this outbreak had a clonal origin. The high
transmission rate of W-135 carriage from pilgrims to
household contacts translated into a high attack rate of W-
135 meningococcal disease among contacts in 2001 (17).
We investigated carriage rates in pilgrims returning from
the 2002 Hajj to determine whether W-135 was still a
problem, and we compared the strains from 2002 with
those from 2001 to document the evolving molecular epi-
demiology of Hajj-associated W-135 strains.
The Study
We conducted a prospective study on the acquisition of
meningococcal carriage in Singaporean Hajj pilgrims on
the Hajj 2002. We used the same design and methods as we
used in our previous study for the Hajj 2001, and the study
was performed by the same research and laboratory staff
(15). Pilgrims were recruited consecutively at the time of
vaccination with quadrivalent meningococcal and influen-
za vaccine at a Muslim center that performs mass vaccina-
tions for pilgrims referred by numerous national Muslim
travel agencies. A swab sample was taken from both ton-
sils and the pharyngeal wall, by using a standard tech-
nique, and immediately transferred to a plate of selective
culture medium (Oxoid GC, Basingstoke, UK). Repeat
swab samples were taken 2 weeks after return from the pil-
grimage. Returning pilgrims were asked if the symptoms
of upper respiratory tract infection had occurred and if
antibiotic drugs were taken during the pilgrimage, specifi-
cally a single dose of ciprofloxacin. All study participants
gave written informed consent. The study was approved by
the Ethics Committee of Tan Tock Seng Hospital. 
Culture plates were immediately put in candle jars,
transferred to the laboratory within 2 to 4 hours of collec-
tion, incubated at 37°C in humidified air with 5% carbon
dioxide, and examined for bacterial growth at 24 and 48
hours (18). Identification of isolates as N. meningitidis was
performed by traditional methods and was confirmed by
API NH (BioMerieux SA, Lyon, France). The serogroup
was determined by slide agglutination with polyvalent sera
and serogroup-specific sera (A, B, C, D, Y, W-135, X, and
Z) (Murex, Dartford, UK).
PFGE was performed on all meningococcal isolates by
using previously described methods (19). The restriction
enzyme used was SpeI. Multilocus sequence typing
(MLST) was performed on all W-135 isolates, as well as
on stored isolates from the 2001 Hajj, as described by
Maiden et al. (20) by sequencing of seven housekeeping
genes. Primers, determination of sequence alleles, and des-
ignation of sequence types are described on the MLST
Web site (available from: URL: http://neisseria.org/
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of Health, Singapore nm/typing/mlst). Participant demographics, duration of
stay at the Hajj, respiratory symptoms, antibiotic intake,
carriage rates, and results of PFGE and MLST were com-
pared with the findings by our group from Singaporean pil-
grims returning from the Hajj 2001 (15). 
Conclusions
Tonsillopharyngeal swab samples were taken from 193
Malay pilgrims at a median time of 30 days (range 18–52)
before their departure for the Hajj.  One hundred fifty-
three (79%) had a repeat swab sample taken at a median
time of 10 days (range 2–17) after their return from the
Hajj. The mean age was 48 (SD 8.07) years, and 48% were
male. The mean duration of stay was 33 days (range
14–41, SD 3.6). Returning pilgrims reported cough (70%)
and use of antibiotics (52.9%). Nine percent of pilgrims
reported ciprofloxacin use. 
Four of the pilgrims (2.6%) were carriers before the
Hajj. Three isolates could not be grouped; one was
serogroup B. Two (1.3%) of the returning pilgrims were
carriers, and both isolates were serogroup W-135. The
PFGE patterns of the two isolates of W-135 differed from
each other by >10 bands, and each differed by >7 bands
from the predominant PFGE pattern identified in the 2001
Hajj (15). 
On MLST, these two isolates were sequence type (ST)-
192 and ST-32 and shared only one of seven alleles with
each other. They shared none of the seven alleles with the
isolates from the 2001 Hajj. Thirty (94%) of the 32 isolates
from the 2001 Hajj pilgrims were ST-11. The Table summa-
rizes the results from the 2002 versus 2001 Hajj pilgrimage.
We documented a low W-135 meningococcal carriage
rate (1.3%) in pilgrims returning from the 2002 Hajj,
which is in stark contrast to the 15% carriage rate in pil-
grims returning from the year 2001 Hajj (15). On multilo-
cus sequence typing, these isolates were ST-192 and ST-32
and not ST-11, which was the dominant sequence type in
returning pilgrims from the year 2001 Hajj. ST-11 is most
commonly associated with the hypervirulent ET-37 com-
plex (6,7). Our strains from the year 2001 Hajj are there-
fore highly likely to be the same as the ET 37 ST-11
responsible for the outbreak in Saudi Arabia (6,7,9). The
two W-135 strains (ST-192 and ST-32) isolated in pilgrims
returning from the 2002 Hajj were clearly distinct, both in
PFGE and MLST, from the W-135 strain (ST-11) isolated
in pilgrims returning from the year 2001 Hajj (15) and are
thus unlikely to have evolved from ST-11 strains circulat-
ing in 2001. Genetically distinct Hajj-compatible pheno-
types were also reported in France in 2002 (21). 
While carriage rates are indicative of the potential of a
meningococcal outbreak, occurrence of disease is ulti-
mately more informative (21). The absence of the hyper-
virulent W-135 ET ST-11 in returning Singaporean pil-
grims from the Hajj 2002 is reflected by an absence of
Hajj-associated clinical cases of W-135 disease in
Singapore in 2002. This finding is also consistent with
international reports that showed a marked decrease in
cases of meningococcal disease in 2002 caused by the Hajj
2000/2001 outbreak strain (21). Therefore, in 2002, the W-
135 carriage was probably also low in pilgrim populations
other than these from Singapore. 
The marked difference in W-135 carriage rates is
unlikely to be due to selection bias or study methods, as we
used the same recruitment strategy, swabbing techniques,
and laboratory methods in 2002 and 2001. Although the
decrease in carriage in the year 2002 could reflect sponta-
neous changes in epidemiologic features of the outbreak, a
number of public health interventions may have played a
role. Influenza vaccination was given in the 2002 cohort
but not in the 2001 cohort, and respiratory symptoms are
known to promote meningococcal transmission (22).
However, these interventions are unlikely to account for
the difference in carriage: frequency of upper respiratory
symptoms were similar (or even more frequent) in the pil-
grims of 2002 compared to the pilgrims of 2001. More rig-
orously enforcing a long-standing policy to administer
antibiotics to pilgrims from Africa upon entry to Saudi
Arabia (5), plus the recent extension of this policy to
Emerging Infectious Diseases • Vol. 9, No. 6, June 2003 735
DISPATCHES
Table. Characteristics of pilgrims returning from the Hajj 2002 compared with those returning from the Hajj 2001
a 
Characteristics 
Returning Hajj pilgrims 2002 
(n=153) 
Returning Hajj pilgrims 2001 
 (n=171) (ref. 15)  p value 
Median age (yrs)  48  48   
Gender (male) (%)  48  46   
Race (Malay) (%)  98  98   
Median interval between return from pilgrimage and 
throat swab in days (range) 
10 (2–17)  17 (1–45) 
 
Median duration of pilgrimage in days (range)  33 (14–41)  33 (3–47)   
Overall meningococcal carriage rate (%)  1.3  17  <0.001 
Carriage of W-135 ST 11 (%)  0  15  <0.001 
Cough (%)  75  56  NS 
Antibiotic drug use (%)  56  41  NS 
aNS, not significant. incoming pilgrims from the Indian subcontinent (23), may
have played a role in decreasing the importation of W-135
to the pilgrim pool. In addition, more liberal use of
ciprofloxacin may have occurred during the 2002 Hajj.
Nine percent of the pilgrims in our cohort reported
ciprofloxacin use. 
However, the main difference between the year 2002
and 2001 Hajj pilgrimages was that coverage with quadri-
valent meningococcal polysaccharide vaccine was only
partial in 2001 (9), whereas almost complete vaccine cov-
erage for this pilgrimage can be assumed for the year 2002
after this vaccine became a Hajj visa requirement for all
pilgrims (21). Although polysaccharide vaccine does not
prevent acquisition of carriage (13), as confirmed in our
2001 cohort (15), polysaccharide vaccines can induce tran-
sient reduction of carriage (24). In addition, vaccines
reduce the incidence of meningococcal disease and thus
circulation of meningococci. Almost complete vaccine
coverage of 2 million pilgrims may have therefore con-
tributed to a decrease in the spread of carriage within this
pilgrim population and consequently reduced transmission
of carriage from returning pilgrims to their contacts. 
The significant decrease of W-135 meningococcal car-
riage and the absence of ST-11 in returning pilgrims from
the Hajj 2002 are important findings with regard to public
health policy. Our documented low W-135 carriage rate in
Singaporean pilgrims in the year 2002 is indicative of a
decreased potential for spread of meningococcal disease in
close contacts of returning pilgrims. On the basis of the
high carriage rate in returning pilgrims, together with the
transmission to household contacts and observed second-
ary cases in the community in 2001 (16,17), we suggested
that administrating antibiotics to returning pilgrims would
be appropriate (15). Indeed, the Saudi Arabia authorities
have implemented such a policy for their returning Saudi
pilgrims (23). However, the epidemiologic features of car-
riage may be changing or has been controlled by vaccina-
tion and administering antibiotic drugs to incoming pil-
grims from countries with high incidence. Thus, the
administration of antibiotics to all returning pilgrims
appears to be unnecessary at the present time. Ongoing
surveillance of carriage rates both in the resident popula-
tion in Saudi Arabia as well as in arriving and departing
pilgrims is paramount for rapid readjustment of a policy to
administer antibiotics to eradicate carriage. 
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